SCHEMBL11255913

SCHEMBL11255913

[Li]C#CCCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11658732 0.97 PTPN7 (0.48)
SCHEMBL9732267 0.97 PTPN7 (0.48)
SCHEMBL8551377 0.97 PTPN7 (0.48)
SCHEMBL8030954 0.97 PTPN7 (0.48)
SCHEMBL7572259 0.97
SCHEMBL1557548 0.90
SCHEMBL10941675 0.88
SCHEMBL1760799 0.83 PTPN7 (0.56)
SCHEMBL23040316 0.80 PTPN7 (0.61)
SCHEMBL11066113 0.80 PTPN7 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4315032-A ANTITHROMBOGENIC AGENTS, ANTIULCER AGENTS TEITIN LIMITED (JP) 1982-02-09 US disclosed
EP-0019475-A2 Process for preparing adjacently disubstituted ketones, novel prostaglandins E1 and anti-thrombotic compositions containing them TEIJIN LIMITED (JP) 1980-11-26 EP disclosed
US-4175201-A Chemical synthesis UNIVERSITY OF CHICAGO (US) 1979-11-20 US disclosed
US-4018820-A Chemical synthesis THE UNIVERSITY OF CHICAGO (US) 1977-04-19 US disclosed